SC Asks Uttarakhand Govt To Finalize Decision On Suspension Of 14 Patanjali Products In Two Weeks

New Delhi: The Supreme Court on Tuesday directed the Uttarakhand government to decide on the suspension of 14 products by yoga guru Ramdev’s Patanjali Ayurved, reported Live Law.

A bench of Justices Hima Kohli and Sandeep Mehta directed the Bharatiya Janata Party government in the state to decide on the matter within two weeks.

On April 29, the Uttarakhand State Licensing Authority for Ayurvedic and Unani Services told the court that the licences were suspended as Patanjali Ayurved had repeatedly violated the 1945 Drugs and Cosmetic Rules.

The 14 drugs that had been suspended were: Swasari Gold, Swasari Vati, Bronchom, Swasari Pravahi, Swasari Avaleh, Mukta Vati Extra Power, Lipidom, Bp Grit, Madhugrit, Madhunashini Vati Extra Power, Livamrit Advance, Livogrit, Eyegrit Gold and Patanjali Drishti Eye Drop.

At the previous hearing on July 9, Patanjali Ayurved told a bench of Justices Hima Kohli and Sandeep Mehta that it had instructed 5,606 franchise stores to withdraw these products.

Media platforms were also instructed to withdraw advertisements for the 14 products, said the company. The court had asked Patanjali Ayurved to file an affidavit within two weeks, stating if social media intermediaries had withdrawn advertisements for the products.

At Tuesday’s hearing, the Indian Medical Association told the court that the 14 products were still available over the counter, even though Patanjali had earlier reportedly stopped their manufacturing.

Patanjali then told the court that the state government cancelled the suspension order on July 1 after considering the report of a committee constituted to look into the matter, reported Live Law.

Related Posts

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) on Wednesday announced that manufacturers may increase prices of scheduled formulations included in the National List of Essential Medicines (NLEM) by 0.64…

Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

New Delhi: The Union Government has clarified that the regulation, licensing, and oversight of hair transplant and cosmetic surgery clinics remain primarily the responsibility of State Governments and Union Territories,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS

24-year-old woman dies during surgery; Five UP doctors booked for negligence

24-year-old woman dies during surgery; Five UP doctors booked for negligence

Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025

Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025